Acute SSRI administration affects the processing of social cues in healthy volunteers

Neuropsychopharmacology

Volumn 28, Issue 1, 2003, Pages 148-152

  Harmer, C J ^a   Bhagwagar, Z ^a   Perrett, D I ^b   Vollm B A ^a   Cowen, P J ^a   Goodwin, G M ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Antidepressant; Citalopram; Emotion; Facialexpressions; Selective serotonin reuptake inhibitor

Indexed keywords

CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ADULT; AFFECT; ANXIETY; ARTICLE; ASSOCIATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EMOTION; FACIAL EXPRESSION; FEMALE; HUMAN; MIDDLE AGED; PERCEPTION; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL;

ADULT; AFFECT; ANXIETY; CITALOPRAM; CUES; DOUBLE-BLIND METHOD; EMOTIONS; FACIAL EXPRESSION; FEMALE; HUMANS; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; SOCIAL PERCEPTION;

EID: 0037209183     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/sj.npp.1300004     Document Type: Article

References (38)

1. Adolphs R, Tranel D, Damasio H, Damasio A (1994). Impaired recognition of emotion in facial expressions following bilateraldamage to the human amygdala [see comments].Nature372:669-672.
2. Adolphs R, Tranel D, Hamann S, Young AW, Calder AJ, Phelps EA etal(1999). Recognition of facial emotion in nine individualswith bilateral amygdala damage.Neuropsychologia37: 1111-1117.
3. Amat J, Matus-Amat P, Watkins LR, Maier SF (1998). Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat.Brain Res812: 113-120.
4. Attenburrow MJ, Mitter PR, Whale R, Terao T, Cowen PJ (2001). Low dose citalopram as a 5-HT neuroendocrine probe.Psychopharmacology155: 323-326.
5. Beasley CM, Masica DN, Potvin JH (1992). Fluoxetine: a review of receptor and functional effects and their clinical implications.Psychopharmacology107: 1-10.
6. Blair RJ, Curran HV (1999). Selective impairment in the recognition of anger induced by diazepam.Psychopharmacology(Berl)147: 335-338.
7. Blier P, De-Montigny C (1994).Current advances and trends in the treatment of depression.Trends PharmcolSci15: 220-226.
8. Bouhuys AL, Geerts E, Gordijn MC (1999). Depressed patients’ perceptions of facial emotions in depressed and remitted statesare associated with relapse: a longitudinal study.J NervMent Dis187: 595-602.
9. Broks P, Young AW, Maratos EJ, Coffey PJ, Calder AJ, Isaac CLet al(1998). Face processing impairments after encephalitis:amygdala damage and recognition of fear.Neuropsychologia36:59-70.
10. Calder AJ, Keane J, Manes F, Antoun N, Young AW (2000). Impaired recognition and experience of disgust following braininjury.Nat Neurosci3: 1077-1078.
11. Davis M, Whalen PJ (2001). The amygdala: vigilance and emotion.Mol Psychiatry6: 13-34.
12. Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME (1992).A functional anatomical study of unipolardepression.J Neurosci12: 3628-3641.
13. Ekman P (1992). An argument for basic emotions.Cognition Emotion6: 169-200.
14. Ekman P, Friesen WV (1976).Pictures of Facial Affect Consulting Psychology.Palo Alto, CA.
15. Fuller RW (1995). Serotonin uptake inhibitors: uses in clinical therapy and in laboratory research.Prog Drug Res45: 167-204.
16. Griebel G, Moreau JL, Jenck F, Misslin R, Martin JR (1994). Acute and chronic treatment with 5-HT reuptake inhibitors differen-tially modulate emotional responses in anxiety models inrodents.Psychopharmacology113: 463-470.
17. Graeff FG, Guimaraes FS, De Andrade TG, Deakin JF (1996).Role of 5-HT in stress, anxiety, and depression.PharmacolBiochemBehav54: 129-141.
18. Gray JM, Young AW, Barker WA, Curtis A, Gibson D (1997). Impaired recognition of disgust in Huntington’s disease genecarriers.Brain120: 2029-2038.
19. Harmer CJ, Perrett DI, Cowen PJ, Goodwin GM (2001). Administration of the beta-adrenoceptor blocker, propranolol, impairs the processing of facial expressions of sadness.Psychopharmacology (Berl)154: 383-389.
20. Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM (2002). Repeated administration of citalopram or reboxetine reduces the percep-tion of negative emotions from facial expression.J of Psycho-pharmacol.16, 70.
21. Hensman R, Guimaraes FS, Wang M, Deakin JF (1991).Effects of ritanserin on aversive classical conditioning in humans.Psychopharmacology (Berl)104: 220-224.
22. Inoue T, Koyama T, Yamashita I (1993). Effect of conditioned fear stress on serotonin metabolism in the rat brain.PharmacolBiochemBehav44: 371-374.
23. Kawahara H, Yoshida M, Yokoo H, Nishi M, Tanaka M (1993). Psychological stress increases serotonin release in the amygdalaand prefrontal cortex assessed byin vivomicrodialysis.NeurosciLett162: 81-84.
24. Kent JM, Coplan JD, Gorman JM (1998). Clinical utility of the selective serotonin reuptake inhibitors in the spectrum ofanxiety.Biol Psychiatry44: 812-824.
25. Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RCet al(1998). Selective alteration of personality and social behaviorby serotonergic intervention.Am J Psychiatry155: 373-379.
26. Maren S (2001). Neurobiology of Pavlovian fear conditioning.Annu Rev Neurosci24: 897-931.
27. Morris JS, Frith CD, Perrett DI, Rowland D, Young AWet al (1996).A differential neural response in the human amygdala tofearful and happy facial expressions.Nature383: 812-815.
28. Moskowitz DS, Pinard G, Zuroff DC, Annable L, Young SN (2001). The effect of tryptophan on social interaction in everyday life: aplacebo-controlled study.Neuropsychopharmacology25: 277-289.
29. Phillips ML, Young AW, Scott SK, Calder AJ, Andrew C, Giampietro Vet al(1998). Neural responses to facial and vocalexpressions of fear and disgust.Proc R SocLond B BiolSci265:1809-1817.
30. Phillips ML, Young AW, Senior C, Brammer M, Andrew C, Calder AJet al(1997). A specific neural substrate for perceiving facialexpressions of disgust.Nature389: 495-498.
31. Raleigh MJ, McGuire MT, Brammer GL, Pollack DB, Yuwiler A (1991). Serotonergic mechanisms promote dominance acquisi-tion in adult male vervet monkeys.Brain Res559: 181-90.
32. Rapcsak SZ, Galper SR, Comer JF, Reminger SL, Nielsen L, Kaszniak AWet al(2000). Fear recognition deficits after focalbrain damage: a cautionary note.Neurology54: 575-581.
33. Rauch SL, Whalen PJ, Shin LM, McInerney SC, Macklin ML, Lasko NB (2000). Exaggerated amygdala response to masked facialstimuli in posttraumatic stress disorder: a functional MRI study.Biol Psychiatry47: 769-776.
34. Silva M, Hetem LA, Guimaraes FS, Graeff FG (2001).Opposite effects of nefazodone in two human models of anxiety.Psychopharmacology (Berl)156: 454-460.
35. Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA (2001). Increased amygdala response to maskedemotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study.Biol Psychiatry50: 651-658.
36. vonZerrsen D, Strian F, Schwarz D (1974). Evaluation of depressive states, especially in longitudinal studies. In: Pichit P(ed).Psychological Measurements in Psychopharmacology.Basel, Switzerland: Karger, pp 189-202.
37. Young AW, Rowland D, Calder AJ, Etcoff NL, Seth A, Perrett DI (1997). Facial expression megamix: tests of dimensional andcategory accounts of emotion recognition.Cognition63:271-313.
38. Zangara A, Blair RJ, Curran HV (2002). A comparison of the effects of a beta-adrenergic blocker and a benzodiazepine upon therecognition of human facial expressions.Psychopharm163: 36-41.